Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity.
Sophia SheikhTaylor MunsonGerard GarvanClaire LaytonDawn SolleeColleen CowderyAlexa PetersonLindsay Schaack RothsteinMorgan HensonHayley GartnerMichael UjhelyiPublished in: Drugs - real world outcomes (2024)
Based on our study population, DIF therapy appears to be beneficial in limiting duration of toxicity and intensive care unit lengths of stay in digoxin toxic patients. Although DIF was appropriately utilized in most cases, there was a relatively high proportion of cases in which DIF treatment was either underutilized or not indicated.
Keyphrases
- intensive care unit
- end stage renal disease
- oxidative stress
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- stem cells
- metabolic syndrome
- skeletal muscle
- mechanical ventilation
- mesenchymal stem cells
- oxide nanoparticles
- replacement therapy
- acute respiratory distress syndrome